Michał Ząbczyk

2.3k total citations · 1 hit paper
135 papers, 1.6k citations indexed

About

Michał Ząbczyk is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Michał Ząbczyk has authored 135 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cardiology and Cardiovascular Medicine, 57 papers in Pulmonary and Respiratory Medicine and 46 papers in Internal Medicine. Recurrent topics in Michał Ząbczyk's work include Venous Thromboembolism Diagnosis and Management (46 papers), Blood properties and coagulation (41 papers) and Atrial Fibrillation Management and Outcomes (34 papers). Michał Ząbczyk is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (46 papers), Blood properties and coagulation (41 papers) and Atrial Fibrillation Management and Outcomes (34 papers). Michał Ząbczyk collaborates with scholars based in Poland, United States and Germany. Michał Ząbczyk's co-authors include Anetta Undas, Joanna Natorska, Anetta Undas, Krzysztof Piotr Malinowski, Robert A.S. Ariëns, Marcin Sadowski, Piotr Mazur, Krzysztof Plens, Jacek Majewski and Saulius Butenas and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Michał Ząbczyk

125 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice

2023 80 citations Michał Ząbczyk, Robert A.S. Ariëns et al. Cardiovascular Research profile →

Peers

Michał Ząbczyk

CCM

PRM

HEMAT

EPIDE

Joanna Natorska Poland

Prakash Saha United Kingdom

Suzanne Fateh‐Moghadam Germany

Zsuzsanna Bereczky Hungary

M.F. Aillaud France

Maria M. Aleman United States

Bryce A. Kerlin United States

Petra Stohlawetz Austria

Nadine Ajzenberg France

KA Bauer United States

Joanna Natorska Poland

Michał Ząbczyk

692 ×1.1

CCM

383 ×0.7

PRM

241 ×0.6

203 ×0.5

HEMAT

260 ×0.9

EPIDE

Citations per year, relative to Michał Ząbczyk Michał Ząbczyk (= 1×) peers Joanna Natorska

Countries citing papers authored by Michał Ząbczyk

Since Specialization

Citations

This map shows the geographic impact of Michał Ząbczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Ząbczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Ząbczyk more than expected).

Fields of papers citing papers by Michał Ząbczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Ząbczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Ząbczyk. The network helps show where Michał Ząbczyk may publish in the future.

Co-authorship network of co-authors of Michał Ząbczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Ząbczyk. A scholar is included among the top collaborators of Michał Ząbczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Ząbczyk. Michał Ząbczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ząbczyk, Michał. (2025). Incredible fibrin(ogen): from basic mechanisms to clinical implications. Jagiellonian University Repository (Jagiellonian University). 1 indexed citations

Ząbczyk, Michał, et al.. (2025). Duration‐Dependent Effects of Rivaroxaban on Inflammation and Valve Calcification in Aortic Stenosis: Clinical and In Vitro Insights. Journal of Cellular and Molecular Medicine. 29(21). e70927–e70927. 1 indexed citations

Ząbczyk, Michał, et al.. (2025). Statin treatment reduces protein carbonylation in patients with COPD: A randomized controlled study. European Journal of Clinical Investigation. 55(4). e70009–e70009. 1 indexed citations

Musiał, Jacek, et al.. (2025). Antiphospholipid antibodies and atherosclerotic vascular disease: recent advances. Rheumatology International. 45(12). 279–279.

Ząbczyk, Michał, et al.. (2024). Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis. Scandinavian Journal of Clinical and Laboratory Investigation. 84(4). 257–267. 2 indexed citations

Konieczyńska, Małgorzata, Joanna Natorska, Michał Ząbczyk, & Anetta Undas. (2024). Lp(a) and thromboembolism: current state of knowledge and unsolved issues. Archives of Medical Science. 20(6). 1770–1783. 1 indexed citations

Ząbczyk, Michał, et al.. (2024). Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation. Journal of Thrombosis and Haemostasis. 22(10). 2797–2809. 1 indexed citations

Ząbczyk, Michał, Joanna Natorska, Paweł T. Matusik, et al.. (2023). Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation. Translational Stroke Research. 15(4). 773–783. 3 indexed citations

Natorska, Joanna, Jan Bembenek, Anna Członkowska, et al.. (2023). Protein Carbonylation Contributes to Prothrombotic Fibrin Clot Phenotype in Acute Ischemic Stroke: Clinical Associations. Stroke. 54(11). 2804–2813. 10 indexed citations

10.

Malinowski, Krzysztof Piotr, et al.. (2023). Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease. European Journal of Clinical Investigation. 53(9). e14007–e14007. 6 indexed citations

11.

Ząbczyk, Michał, et al.. (2023). Enhanced neutrophil extracellular traps formation in AF patients with dilated left atrium. European Journal of Clinical Investigation. 53(5). e13952–e13952. 11 indexed citations

12.

Słomka, Artur, Radosław Litwinowicz, Magdalena Bartuś, et al.. (2023). Postoperative Coagulation Changes in Patients after Epicardial Left Atrial Appendage Occlusion Varies Based on the Left Atrial Appendage Size. SHILAP Revista de lepidopterología. 12(1). 8–8. 6 indexed citations

13.

Natorska, Joanna, Javier Corral, María Eugenia de la Morena‐Barrio, et al.. (2023). Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype. Thrombosis and Haemostasis. 123(9). 880–891. 8 indexed citations

14.

Ząbczyk, Michał, Robert A.S. Ariëns, & Anetta Undas. (2023). Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovascular Research. 119(1). 94–111. 80 indexed citations breakdown →

15.

Natorska, Joanna, Michał Ząbczyk, Olga Trojnarska, et al.. (2022). Dissimilarity in coagulation system in adults after Fontan surgery based on thrombin generations. European Journal of Cardio-Thoracic Surgery. 63(1). 1 indexed citations

16.

Ząbczyk, Michał, Joanna Natorska, Agnieszka Janion−Sadowska, et al.. (2021). Isoprostane‐8 and GDF‐15 as novel markers of post‐PE syndrome: Relation with prothrombotic factors. European Journal of Clinical Investigation. 52(1). e13660–e13660. 3 indexed citations

17.

Ząbczyk, Michał, et al.. (2019). A Prothrombotic State in Patients With a History of Left Ventricular Thrombus. The American Journal of Cardiology. 123(8). 1358–1363. 9 indexed citations

18.

Ząbczyk, Michał, et al.. (2019). DOAC-Remove abolishes the effect of direct oral anticoagulants on activated protein C resistance testing in real-life venous thromboembolism patients. Clinical Chemistry and Laboratory Medicine (CCLM). 58(3). 430–437. 14 indexed citations

19.

Ząbczyk, Michał, et al.. (2019). The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Clinical Chemistry and Laboratory Medicine (CCLM). 57(9). 1374–1381. 42 indexed citations

20.

Zaręba, Lech, et al.. (2019). Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations. Disease Markers. 2019. 1–7. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact